Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma

Addition of induction chemotherapy (IC) to concurrent chemoradiotherapy (CC) is an encouraging first-line treatment strategy for patients with locoregionally advanced nasopharyngeal carcinoma (NPC). We evaluated the clinical efficacy and toxicity of addition of gemcitabine plus cisplatin (GP) IC to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fangzheng, Wang, Quanquan, Sun, Chuner, Jiang, Lei, Wang, Fengqin, Yan, Zhimin, Ye, Tongxin, Liu, Min, Xu, Peng, Wu, Haitao, Jiang, Aizawa, Rihito, Sakamoto, Masoto, Yuezhen, Wang, Zhenfu, Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722524/
https://www.ncbi.nlm.nih.gov/pubmed/29228572
http://dx.doi.org/10.18632/oncotarget.18245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722524/
https://www.ncbi.nlm.nih.gov/pubmed/29228572
http://dx.doi.org/10.18632/oncotarget.18245

Ejemplares similares